{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:25:32Z","timestamp":1787034332768,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"DOI":"10.1007\/s12328-026-02427-9","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:38:13Z","timestamp":1787031493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful administration of glecaprevir\/pibrentasvir via percutaneous endoscopic gastrostomy in a pediatric patient with chronic hepatitis C and spinal muscular atrophy receiving risdiplam"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0981-7161","authenticated-orcid":false,"given":"Marta","family":"Carfagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Carciofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Palpacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Andresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria Felicita","family":"Garzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Campioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zallocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2427_CR1","doi-asserted-by":"publisher","DOI":"10.54394\/CJQU6666","volume-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"2427_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S2468-1253(19)30385-1","volume":"5","author":"J Schmelzer","year":"2020","unstructured":"Schmelzer J, Dugan E, Blach S, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020;5:374\u201392.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2427_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4:477\u201387. Epub 2019 Apr 11.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2427_CR4","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.xphs.2018.02.015","volume":"107","author":"RK Oberoi","year":"2018","unstructured":"Oberoi RK, Zhao W, Sidhu DS, et al. A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir\/Pibrentasvir Tablets on Exposures in Healthy Subjects. J Pharm Sci. 2018;107:1724\u201330.","journal-title":"J Pharm Sci"},{"key":"2427_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12328-019-00997-5","volume":"12","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y, Tateishi R, Koike K. Successful treatment of chronic hepatitis C virus infection with crushed glecaprevir\/pibrentasvir administered via a percutaneous endoscopic gastrostomy tube: case report and review of the literature. Clin J Gastroenterol. 2019;12:588\u201391.","journal-title":"Clin J Gastroenterol"},{"issue":"4","key":"2427_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S2352-4642(18)30037-3","volume":"2","author":"G Indolfi","year":"2018","unstructured":"Indolfi G, Serranti D, Resti M. Direct- Acting Antivirals for Children and Adolescents With Chronic Hepatitis C. Lancet Child Adolesc Health. 2018;2(4):298\u2013304.","journal-title":"Lancet Child Adolesc Health"},{"key":"2427_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.30840","volume":"71","author":"MM Jonas","year":"2020","unstructured":"Jonas MM, Squires RH, Rhee SM, et al. Pharmacokinetics, Safety, and Efficacy of Glecaprevir\/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study. Hepatology. 2020;71:456\u201362.","journal-title":"Hepatology"},{"key":"2427_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/hep.31841","volume":"74","author":"MM Jonas","year":"2021","unstructured":"Jonas MM, Rhee S, Kelly DA, et al. Pharmacokinetics, Safety, and Efficacy of Glecaprevir\/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study. Hepatology. 2021;74:19\u201327.","journal-title":"Hepatology"},{"key":"2427_CR9","doi-asserted-by":"publisher","first-page":"e16180","DOI":"10.1111\/liv.16180","volume":"45","author":"M Stinco","year":"2025","unstructured":"Stinco M, Rubino C, Bartolini E, et al. Effectiveness and Safety of Glecaprevir\/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-World, Multicenter Study. Liver Int. 2025;45:e16180.","journal-title":"Liver Int"},{"key":"2427_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/0897190017731245","volume":"31","author":"L Jindracek","year":"2018","unstructured":"Jindracek L, Stark J. Treatment of chronic hepatitis C virus infection with crushed ledipasvir\/sofosbuvir administered via a percutaneous endoscopic gastrostomy tube. J Pharm Pract. 2018;31:522\u20134.","journal-title":"J Pharm Pract"},{"key":"2427_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jcpt.12713","volume":"43","author":"JE Yap","year":"2018","unstructured":"Yap JE, Jaiswal P, Ton L, et al. Successful treatment of chronic hepatitis C infection with crushed elbasvir\/grazoprevir administered via a percutaneous endoscopic gastrostomy tube. J Clin Pharm Ther. 2018;43:730\u20132.","journal-title":"J Clin Pharm Ther"},{"key":"2427_CR12","doi-asserted-by":"publisher","first-page":"ofab525","DOI":"10.1093\/ofid\/ofab525","volume":"8","author":"K Whelchel","year":"2021","unstructured":"Whelchel K, Zuckerman AD, Koren DE, et al. Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review. Open Forum Infect Dis. 2021;8:ofab525. https:\/\/doi.org\/10.1093\/ofid\/ofab525.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"2427_CR13","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.healun.2020.01.941","volume":"39","author":"G Waldman","year":"2020","unstructured":"Waldman G, Bethea E, Gustafson J, et al. Use of Crushed Glecaprevir\/Pibrentasvir in Hepatitis C Positive Donor Heart Transplant Recipients. J Heart Lung Transplantation. 2020;39(4):S96.","journal-title":"J Heart Lung Transplantation"},{"key":"2427_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40263-022-00910-8","volume":"36","author":"J Paik","year":"2022","unstructured":"Paik J, Risdiplam. A Review in Spinal Muscular Atrophy. CNS Drugs. 2022;36:401\u201310.","journal-title":"CNS Drugs"},{"key":"2427_CR15","unstructured":"National Center for Biotechnology Information. (2026). PubChem Compound Summary for CID 118513932, Risdiplam. Retrieved July 23, 2026 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Risdiplam"},{"key":"2427_CR16","unstructured":"AbbVie, Maviret. EU summary of product charac teristics. 2021. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/maviret-epar-productinformation_en.pdf"},{"key":"2427_CR17","first-page":"1135","volume":"18","author":"AM Alamri","year":"2025","unstructured":"Alamri AM, Almehman WA, Albuhairy AM, et al. Management of Pediatric Chronic Hepatitis C with Crushed or Split Glecaprevir\/Pibrentasvir: A Case Series From East Jeddah Hospital, Saudi Arabia. Int Med Case Rep J. 2025;18:1135\u201340.","journal-title":"Int Med Case Rep J"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02427-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02427-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02427-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:38:14Z","timestamp":1787031494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02427-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":17,"alternative-id":["2427"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02427-9","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The off-label use of GLE\/PIB via PEG was prescribed under the direct responsibility of the treating physician, in accordance with Italian Law 94\/1998, and registered with the Hospital Executive Management per institutional procedures.","order":2,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles for the Declaration of Helsinki for medical research involving human participants.","order":3,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for the off-label treatment and for publication of this case report was obtained from the patient\u2019s legal guardians.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}